The 2 Minute Medicine® Podcast

In this episode, we begin by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Teplizumab and beta-cell function in newly diagnosed type 1 diabetes.” Then we take a closer look at allergies and new treatments on the horizon for food allergies. Next, a discussion about lung cancer, following the recent passing of Andre Braugher. Last but not least, we discuss New Year’s resolutions along with evidence-based ways to make them last and explore the rise in cases of counterfeit Ozempic use, and how this has affected the world. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the Annals of Internal Medicine and is entitled “Cardiovascular health of middle-aged US adults by income level, 1999 to March 2020: A serial cross-sectional study.” In the second half, we begin by discussing an increasingly popular procedure used in infants who are struggling with breastfeeding. Then we delve into the new findings that a hormone, GDF15, is linked to morning sickness. After this, we discuss ketamine, the drug that was implicated in the tragic passing of 'Friends' star Matthew Perry. Finally, we end with a conversation about the ongoing generic drug shortages occurring across the country.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Trial of Botulinum Toxin for Isolated or Essential Head Tremor”. In the second half, we discuss how as semaglutide, also known by brand names Ozempic or Wegovy, continues to make headlines, a new drug called Zepbound is entering the weight loss sphere. Next, we discuss organ transplants and a new antibiotics developed for the treament of  gonorrhea, Zoliflodacin. Last but not least, we discuss why ⁠March of Dimes⁠, a maternal and infant health organization, issued ⁠a D+ to the USA⁠ for the 2nd year in a row for its relatively high rate of preterm births.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠⁠https://bit.ly/2zZnJt9⁠

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper”. Next, in the second half, we begin by discussing the UK's approval of the first licensed medication using CRISPR technology. Next, we will dive into the American Heart Association's decision to remove race as one of the biological risk factors for cardiovascular disease in their cardiac risk algorithm. Then we will discuss the news of NBA player CJ McCollum's pneumothorax, and finally we will end with a conversation about a recent finding that the life expectancy gap between men and women has widened. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from Pediatrics, entitled “HIV Preexposure Prophylaxis Provision among Adolescents: 2018 to 2021”.  We then dive deeper into a discussion about seasonal affective disorder, its treatment, and its impact on the population. Then we take a closer look at the Movember movement and how it relates to men’s health. After that, we discuss the recent surge in syphilis cases and what can be done about it. Last, but not least, we have a conversation about substance use disorders in the wake of Matthew Perry’s passing. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from Pediatrics, entitled “COVID-19 Vaccine Hesitancy Among Parents: A Qualitative Study”. In the second half of our episode, we start off by discussing the issue of performance-enhancing drugs in sports following the news of a  banned substance scandal in the men's marathon. Next, we will dive into the NHL's Pride Tape ban and their decision to reverse the ban following public push-back. Finally, we end with conversations about the bedbug outbreak in Paris, and new studies highlighting the value of wearable technology in diagnosing and monitoring Parkinson's disease. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled ““Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.” In the second half of our episode, we begin by taking a closer look at the public heath crisis in Gaza. Next, we discuss a recently published study in JAMA, and examine the possible link between ADHD and Dementia. Last but not least, a short discussion about the significance of October being National Pregnancy and Infant Loss Awareness Month. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH”. In the second half of our episode, we begin by exploring the recently announced price drop for a popular tuberculosis test. Then we discuss Sufjan Stevens' ongoing battle with the rare autoimmune condition, Guillain-Barre Syndrome. Finally, we end with a conversation about newly developed tests to identify medical abortions and the ongoing American Red Cross blood supply shortage. 

We begin this episode by discussing our article of the week from JAMA Network Open, entitled “Women’s Adherence to Healthy Dietary Patterns and Outcomes of Infertility Treatment”. In the second half of our episode, we begin with a discussion about Shohei Ohtani, the superstar baseball player fighting against a torn ligament. Next, we look at blue light glasses, an increasingly popular way to combat eye strain in the digital world. After that, we discuss sciatica, and how this disease affects the lives of many, including some famous names. Finally, we discuss the long-term and short-term impacts of concussion and CTE.

We begin this episode by discussing our article of the week from the Lancet “Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA”. In the second half of our episode, we begin with a discussion of Wegovy and the latest data on its human use. Next, we discuss congenital heart disease in sports. Following that, we examine the latest developments with the COVID-19 virus, and last but not least, we examine the recent news about long-lasting chemicals found in paper straws, and their impact on human health.